Transgenic analysis of scleroderma: understanding key pathogenic events in vivo
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 3 (4) , 285-293
- https://doi.org/10.1016/j.autrev.2003.10.003
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Skeletal development: insights from targeting the mouse genomeThe Lancet, 2003
- Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell ActivationThe Journal of Immunology, 2002
- Disrupting theIL-4gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblastsProceedings of the National Academy of Sciences, 2002
- Development of the tight-skin phenotype in immune-deficient miceArthritis & Rheumatism, 2001
- Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chlorideArthritis & Rheumatism, 2000
- Effect of Superoxide Dismutase on Bleomycin-Induced Dermal Sclerosis: Implications for the Treatment of Systemic SclerosisJournal of Investigative Dermatology, 1999
- Role and interaction of connective tissue growth factor with transforming growth factor-? in persistent fibrosis: A mouse fibrosis modelJournal of Cellular Physiology, 1999
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.Genome Research, 1996
- The tight skin 2 mouseArthritis & Rheumatism, 1995